Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong

IMPORTANCE: Diabetes and COVID-19 are both global pandemics, and type 2 diabetes is a common comorbidity in patients with acute COVID-19 and is proven to be a key determinant of COVID-19 prognosis. Molnupiravir and nirmatrelvir-ritonavir are oral antiviral medications recently approved for nonhospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, David T. W., Chung, Matthew S. H., Lau, Eric H. Y., Lau, Kristy T. K., Au, Ivan C. H., Lee, Chi Ho, Woo, Yu Cho, Wong, Carlos K. H., Cowling, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199353/
https://www.ncbi.nlm.nih.gov/pubmed/37204790
http://dx.doi.org/10.1001/jamanetworkopen.2023.14393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199353/
https://www.ncbi.nlm.nih.gov/pubmed/37204790
http://dx.doi.org/10.1001/jamanetworkopen.2023.14393

Ejemplares similares